5

Ovarian cancer

Year:
2014
Language:
english
File:
PDF, 1.45 MB
english, 2014
20

How participants in cancer trials are chosen: ethics and conflicting interests

Year:
2006
Language:
english
File:
PDF, 228 KB
english, 2006
23

Platelet-derived growth factor receptor (PDGFR): A target for anticancer therapeutics

Year:
2005
Language:
english
File:
PDF, 121 KB
english, 2005
29

The ethical and scientific case for phase 2C clinical trials

Year:
2010
Language:
english
File:
PDF, 77 KB
english, 2010
30

VEGF inhibitors and advanced ovarian cancer

Year:
2011
Language:
english
File:
PDF, 60 KB
english, 2011
33

Vascular endothelial growth factor antagonists as anticancer agents

Year:
2004
Language:
english
File:
PDF, 170 KB
english, 2004
41

Oligosaccharides as anti-angiogenic agents

Year:
2008
Language:
english
File:
PDF, 194 KB
english, 2008
43

PARP inhibitors in BRCA mutation-associated ovarian cancer

Year:
2015
Language:
english
File:
PDF, 194 KB
english, 2015
47

Angiogenesis as a target for the treatment of ovarian cancer

Year:
2013
Language:
english
File:
PDF, 367 KB
english, 2013